Prolotherapy: An effective therapy for Tietze syndrome

Area of Science:

• Orthopedics
• Pain Management
• Regenerative Medicine

Background:

• Tietze syndrome is a rare, benign inflammatory disorder characterized by chest pain and localized swelling.
• Conservative therapies, primarily analgesics, are the standard treatment, but may not be effective for all patients.

Purpose of the Study:

• To compare the short-term efficacy of prolotherapy versus conservative therapy for Tietze syndrome.
• To evaluate pain reduction and clinical outcomes in patients with Tietze syndrome.

Main Methods:

• A comparative study involving 21 patients receiving prolotherapy and 13 patients receiving conservative therapy (NSAIDs).
• Pain intensity was measured using a Visual Analogue Scale (VAS) at baseline and at multiple follow-up points.
• Clinical and radiological evidence was assessed to compare treatment effects.

Main Results:

• Both groups showed a reduction in VAS scores, but prolotherapy demonstrated a faster and more significant decrease in pain.
• The prolotherapy group experienced significantly reduced clinical findings (p=0.001), indicating a faster recovery.
• No significant differences were observed in age, sex, comorbidity, or radiological evidence between the groups.

Conclusions:

• Prolotherapy is a safe and potentially favorable long-term treatment option for Tietze syndrome.
• It may be particularly beneficial for patients who experience adverse drug events or have comorbidities affecting liver or kidney function.